Occurrence and Fate of Human Pharmaceuticals in the Environment

  • Sara C. Monteiro
  • Alistair B.A. Boxall
Part of the Reviews of Environmental Contamination and Toxicology book series (RECT, volume 202)


Pharmaceuticals from a wide spectrum of therapeutic classes are used in human medicine worldwide. Pharmaceutically active compounds are defined as substances used for prevention, diagnosis or treatment of a disease and for restoring, correcting or modifying organic functions (Daughton and Ternes 1999). Pharmaceuticals include more than 4000 molecules with different physico-chemical and biological properties and distinct modes of biochemical action (Beausse 2004). Most medical substances are administrated orally. After administration, some drugs are metabolised, while others remain intact before being excreted. Therefore, a mixture of pharmaceuticals and their metabolites will enter municipal sewage and sewage treatment plants (STP; Kümmerer 2004).


  1. Ahel M, Jeličić I (2001) Phenazone Analgesics in Soil and Groundwater below a Municipal Solid Waste Landfill. In: Daughton CG and Jones-Lepp T (eds), American Chemical Society, Symposium series 791, Washington, DC, pp. 100–115.Google Scholar
  2. Ahrer W, Scherwenk E, Buchberger W (2001) Determination of drug residues in water by the combination of liquid chromatography or capillary electrophoresis with electrospray mass spectrometry. J Chromatogr A 910:69–78.CrossRefGoogle Scholar
  3. Alder AC, McArdell CS, Golet EM, Ibric S, Molnar E, Nipales NS, Giger W (2001) In: Daughton CG and Jones-Lepp T (eds), American Chemical Society, Symposium series 791, Washington D.C, pp 56–69.Google Scholar
  4. Alexy R, Kümpel T, Kümmerer K (2004) Assessment of degradation of 18 antibiotics in the Closed Bottle Test. Chemosphere 57:505–512.CrossRefGoogle Scholar
  5. Analgesics. In: An A-Z of Medicinal Drugs. Oxford University Press 2000. Oxford Reference online. Oxford University Press. York University (accessed 18 January 2007) online
  6. Andersen H, Siegrist H, Halling-Sørensen B, and Ternes TA (2003) Fate of estrogens in a municipal sewage treatment plant. Environ Sci Technol 37 (18): 4021–4026.CrossRefGoogle Scholar
  7. Andersen HR, Hansen M, Kjølhot J, Stuer-Lauridsen F, Ternes TA, Halling-Sørensen B (2005) Assessment of the importance of sorption for steroid estrogens removal during activated sludge treatment. Chemosphere 61:139–146.CrossRefGoogle Scholar
  8. Anderson PO, Knoben JE, Troutman WG (2002) Handbook of Clinical Drug Data 10th Ed, McGraw-Hill, USA.Google Scholar
  9. Andreozzi R, Caprio V, Insola A, Marotta R (1999) Advanced oxidation processes (AOP) for water purification and recovery. Catal Today 53 (1): 51–59.CrossRefGoogle Scholar
  10. Andreozzi R, Marotta R, Pinto G, Pollio A (2002) Carbamazepine in water: persistence in the environment, ozonation treatment and preliminary assessment on algal toxicity. Water Res 36 (11): 2869–2877.CrossRefGoogle Scholar
  11. Andreozzi R, Raffaele M, Nicklas P (2003) Pharmaceuticals in STP effluents and their solar photodegradation in the aquatic environment. Chemosphere 50:1319–1330.CrossRefGoogle Scholar
  12. Andreozzi R, Caprio V, Ciniglia C, De Champdoré M, Lo Giudice R, Marotta R, Zuccato E (2004) Antibiotics in the environment: occurrence in Italian STPs, fate and preliminary assessment on algal toxicity of amoxicillin. Environ Sci Technol 38 (24): 6832–6838.CrossRefGoogle Scholar
  13. Andreozzi R, Canterino M, Giudice RL, Marotta R, Pinto G, Pollio A (2006) Lincomycin solar photodegradation, algal toxicity and removal from wastewaters by means of ozonation. Water Res 40 (3): 630–638.CrossRefGoogle Scholar
  14. Arnold W, McNeill K, Latch DE, Boreen AL (2003) Photochemical fate of pharmaceutical compounds discharged and detected in natural waters. National Grants Competition (USGS-WRRI 104G).Google Scholar
  15. Aronson JK (2001)“Antibiotics and anti-infective drugs” In: The Oxford Companion to Medicine. Lock, S, Last, J.M, Dunea G. (eds) Oxford University Press 2001. Oxford Reference Online. Oxford University Press. York University (accessed 18 January 2007), online-
  16. Artola-Garicano E, Borkent I, Damen K, Jager T, Vaes WH (2003) Sorption kinetics and microbial biodegradation activity of hydrophobic chemicals in sewage sludge: model and measurements based on free concentrations. Environ Sci Technol 37:116–122.CrossRefGoogle Scholar
  17. Ashton D, Hilton M, Thomas KV (2004) Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci Tot Environ 333:167–184.CrossRefGoogle Scholar
  18. Balcioğlu IA and Ötker M (2003) Treatment of pharmaceutical wastewater containing antibiotics by O3and O3/ H2O2 processes. Chemosphere 50:85–95.CrossRefGoogle Scholar
  19. Baldessarini RJ (2001) Drugs and the treatment of psychiatric disorders: Depression and Anxiety Disorders. In: Hardman JG, Limbird LE (eds) Goodman & Gilman's - The Pharmacological Basis of Therapeutics 10th Ed, McGraw-Hill, New York, USA, pp 447–484.Google Scholar
  20. Beausse J (2004) Selected drugs in solid matrices: a review of environmental occurrence, determination and properties of principal substances. Trends Anal Chem 23 (10–11): 753–761.CrossRefGoogle Scholar
  21. Bedner M and MacCrehan WA (2006) Transformation of acetaminophen by chlorination produces the toxicants 1,4-benzoquinone and N-acetyl-p-benzoquinone imine. Environ Sci Technol 40 (2): 516–522.CrossRefGoogle Scholar
  22. Belfroid AC, Van der Horst A, Vethaak AD, Schäfer AJ, Rijs GBJ, Wegener J, Cofino WP (1999) Analysis and occurrence of estrogenic hormones and their glucuronides in surface water and waste water in The Netherlands. Sci Tot Environ 225:101–108.CrossRefGoogle Scholar
  23. Bendz D, Paxéus N, Ginn TR, Loge FJ (2005) Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden. J Hazard Mater 122:195–204.CrossRefGoogle Scholar
  24. Bernard S and Gray NF (2000) Aerobic digestion of pharmaceutical and domestic wastewater sludges at ambient temperature. Water Res 34:725–734.CrossRefGoogle Scholar
  25. Bernhard M, Müller J, Knepper TP (2006) Biodegradation of persistent polar pollutants in wastewater: comparison of an optimised lab-scale membrane bioreactor and activated sludge treatment. Water Res 40:3419–3428.CrossRefGoogle Scholar
  26. Besse J-P, Kausch-Barreto C, Garric J (2008) Exposure assessment of pharmaceuticals and their metabolites in the aquatic environment. Application to the French situation and preliminary prioritization. Hum Ecol Risk Assess 14 (4): 665–695.CrossRefGoogle Scholar
  27. Beta-blockers (2000) In: An A-Z of Medicinal Drugs. Oxford University Press 2000. Oxford Reference online. Oxford University Press. York University (accessed 18 January 2007) online-
  28. Boreen AL, Arnold WA, McNeill K (2003) Photodegradation of pharmaceuticals in the aquatic environment: a review. Aquat Sci 65:320–341.CrossRefGoogle Scholar
  29. Boxall ABA, Blackwell PA, Cavallo R, Kay P, Tolls J (2002) The sorption and transport of a sulphonamide antibiotic in soil systems. Toxicol Lett 131:19–28.CrossRefGoogle Scholar
  30. Boxall A (2004) The environmental side effects of medication. EMBO J 5:1110–1116.CrossRefGoogle Scholar
  31. Boxall A, Fogg LA, Blackwell P, Kay P, Pemberton EJ, Croxford A (2004) Veterinary medicines in the environment. Rev Environ Contam Toxicol 180:1–91.CrossRefGoogle Scholar
  32. Boyd GR, Reemstsma H, Grimm DA, Mitra S (2003) Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada. Sci Tot Environ 311:135–149.CrossRefGoogle Scholar
  33. Boyd GR, Palmeri JM, Zhang S, Grimm DA (2004) Pharmaceuticals and personal care products (PPCPs) and endocrine disrupting chemicals (EDCs) in stormwater canals and Bayou St. John in New Orleans, Louisiana, USA. Sci Tot Environ 333:137–148.Google Scholar
  34. Braga O, Smythe GA, Shäfer AI, Feitz AJ (2005) Steroid Estrogens in ocean sediments. Chemosphere 61 (6):827–833.CrossRefGoogle Scholar
  35. Brooks BW, Chambliss CK, Stanley JK, Ramirez A, Banks KE, Johnson RD, Lewis R J (2005) Determination of select antidepressants in fish from an effluent-dominated stream. Environ Toxicol Chem 24:464–469.CrossRefGoogle Scholar
  36. Buser H-R, Müller MD, Theobald N (1998a) Occurrence of the pharmaceutical drug clofibric acid and the herbicide mecoprop in various Swiss Lakes and in the North Sea. Environ Sci Technol 32 (1):188–192.CrossRefGoogle Scholar
  37. Buser H-R, Poiger T, Müller MD (1998b) Occurrence and fate of the pharmaceutical drug diclofenac in surface waters: rapid photodegradation in a lake. Environ Sci Technol 32 (22):3449–3456.CrossRefGoogle Scholar
  38. Buser H-R, Poiger T, Müller MD (1999) Occurrence and environmental behavior of the chiral pharmaceutical drug ibuprofen in surface waters and in wastewater. Environ Sci Technol 33 (15): 2529–2535.CrossRefGoogle Scholar
  39. Calamari D, Zuccato E, Castiglioni S, Bagnati R, Fanelli R (2003) Strategic survey of therapeutic drugs in the rivers Po and Lambro in Northern Italy. Environ Sci Technol 37:1241–1248.CrossRefGoogle Scholar
  40. Calvet R (1989) Adsorption of organic chemicals in soils. Environ Health Perspect 83:145–177.CrossRefGoogle Scholar
  41. Carballa M, Omil F, Lema JM, Llompart M, García-Jares C, Rodríguez I, Gómez, M, Ternes T (2004) Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res 38:2918–2926.CrossRefGoogle Scholar
  42. Carballa M, Omil F, Lema JM (2005) Removal of cosmetic ingredients and pharmaceuticals in sewage primary treatment. Water Res 39 (19): 4790–4796.CrossRefGoogle Scholar
  43. Carballa M, Omil F, Ternes T, Lema JM (2007) Fate of pharmaceutical and personal care products (PPCPs) during anaerobic digestion of sewage sludge. Water Res 41(10): 2139–2150.CrossRefGoogle Scholar
  44. Carballa M, Omil F, Lema JM (2008) Comparison of predicted and measured concentrations of selected pharmaceuticals, fragrances and hormones in Spanish sewage. Chemosphere 72 (8): 1118–1123.CrossRefGoogle Scholar
  45. Chabner BA, Ryan DP, Paz-Ares L, Garcia-Carbonero R, Calabresi P (2001) Antineoplastic agents. In: Hardman JG, Limbird LE (eds) Goodman & Gilman's - The Pharmacological Basis of Therapeutics 10th Ed, McGraw-Hill, New York, USA, pp 1389–1460.Google Scholar
  46. Chambers HF (2001) Antimicrobial agents - general considerations. In: Hardman JG, Limbird LE (eds) Goodman & Gilman's - The Pharmacological Basis of Therapeutics 10th Ed, McGraw-Hill, New York, USA, pp 1143–1170.Google Scholar
  47. Clara M, Kreuzinger N, Strenn B, Gans O, Kroiss H (2005) The solids retention time - a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants. Water Res 39:97–106.CrossRefGoogle Scholar
  48. Collucci M, Bork H, Topp E (2001) Persistence of estrogenic hormones in agricultural soils (I - 17-beta estradiol and estrone). J Environ Qual 30:2070–2076.CrossRefGoogle Scholar
  49. Contrast medium (2002) In: Concise Medical Dictionary. Oxford University Press 2002. Oxford Reference Online. Oxford University Press.York University (accessed 31 January 2007) online
  50. Daughton C, Ternes T (1999) Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ Health Perspect 107:907–938.CrossRefGoogle Scholar
  51. Daughton C (2005) Pharmaceuticals and personal care products in the environment: overarching issues and overview. In: Daughton CG and Jones-Lepp T (eds), American Chemical Society, Symposium series 791, Washington, DC, pp .2–38.Google Scholar
  52. Díaz-Cruz MS, López de Alda MJ, Barceló D (2003) Environmental behavior and analysis of veterinary and human drugs in soil, sediments and sludge. Trends Anal Chem 22:340–351.CrossRefGoogle Scholar
  53. Díaz-Cruz S and Barceló D (2004) Occurrence and analysis of selected pharmaceuticals and metabolites as contaminants present in wastewaters, sludge and sediments. Handb Environ Chem 5:227–260.Google Scholar
  54. Doll TE, Frimmel FH (2003) Fate of pharmaceuticals - photodegradation by simulated solar UV-light. Chemosphere 52:1757–1769.CrossRefGoogle Scholar
  55. Drillia P, Stamatelatou K, Lyberatos G (2005) Fate and mobility of pharmaceuticals in solid matrices. Chemosphere 60 (8): 1034–1044CrossRefGoogle Scholar
  56. Dubus IG, Barriuso E, Calvet R (2001) Sorption of weak organic acids in soils: clofencet 2,4-D and salicylic acid. Chemosphere 45:767–774.CrossRefGoogle Scholar
  57. Environment Agency (2008) Prioritisation of pharmaceuticals of possible environmental concern. R&D technical report, UK.Google Scholar
  58. Erickson BE (2002) Analysing the ignored environmental contaminants. Environ Sci Technol 36:140A-145A.CrossRefGoogle Scholar
  59. EU Landfill Directive (2003) – Strategy & Legislation: Legislation/Directives. DEFRA online
  60. Farré M, Ferrer I, Ginebreda A, Figueras M, Olivella L, Tirapu L, Vilanova M, Barceló D (2001) Determination of drugs in surface water and wastewater samples by liquid chromatography-mass spectrometry: methods and preliminary results including toxicity studies with Vibrio fischeri. J Chromat A 938:187–197.CrossRefGoogle Scholar
  61. Ferrer I, Heine CE, Thurman EM (2004) Combination of LC/TOF-MS and LC/Ion trap MS/MS for the identification of diphenhydramine in sediment samples. Anal Chem 76:14378–1444.Google Scholar
  62. Forsling ML (2001) Hormones. In: The Oxford Companion of the body. Blakemore C and Jennet S. (eds) Oxford University Press 2001. Oxford Reference online. Oxford University Press. York University (accessed 18 January 2007), online-
  63. Galbraith A, Bullock S, Manias S, Hunt B, Richards A (2004) Pharmacokinetics: absorption and distribution. In: Fundamentals of Pharmacology: A Text for Nurses and Health Professionals, 4th Ed. Pearson Education Limited, Essex, England, pp 109–114.Google Scholar
  64. Gibs J, Stackelberg PE, Furlong ET, Meyer M, Zaugg SD, Lippincott RL (2007) Persistence of pharmaceuticals and other organic compounds in chlorinated drinking water as a function of time. Sci Tot Environ 373 (1):240–249.CrossRefGoogle Scholar
  65. Golet EM, Alder AC, Hartmann A, Ternes T, Giger W (2001) Trace determination of fluoroquinolone antibacterial agents in urban wastewater by solid-phase extraction and liquid chromatography with fluorescence detection. Anal Chem 73:3632–3638.CrossRefGoogle Scholar
  66. Golet EM, Alder AC, Giger W (2002a) Environmental exposure and risk assessment of fluoroquinolone antibacterial agents in wastewater and river water of the Glatt Valley watershed, Switzerland. Environ SciTechnol 36(17): 3645–3651.CrossRefGoogle Scholar
  67. Golet EM, Strehler A, Alder AC, Giger W (2002b) Determination of fluoroquinolone antibacterial agents in sewage sludge and sludge-treated soil using accelerated solvent extraction followed by solid-phase extraction. Anal Chem 64 (21): 5455–5462.CrossRefGoogle Scholar
  68. Golet EM, Xifra I, Siegrist H, Alder AC, Giger W (2003) Environmental exposure assessment of fluoroquinolone antibacterial agents from sewage to soil. Environ Sci Technol 37(15): 3243–3249.CrossRefGoogle Scholar
  69. Gómez MJ, Martínez Bueno MJ, Lacorte S, Fernández-Alba AR, Agüera A (2006) Pilot survey monitoring pharmaceuticals and related compounds in sewage treatment plant located on the Mediterranean coast. Chemosphere 66(6): 993–1002.CrossRefGoogle Scholar
  70. Göbel A, McArdell CS, Suter MJF, Giger W (2004) Trace determination of macrolide and sulfonamide antimicrobials, a human sulfonamide metabolite, and trimethoprim in wastewater using liquid chromatography coupled to electrospray tandem mass spectrometry. Anal Chem 76:4756–4764.CrossRefGoogle Scholar
  71. Göbel A, Thomsen A, McArdell CS, Joss A, Giger W (2005) Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment. Environ Sci Technol 39:3981–3989.CrossRefGoogle Scholar
  72. Grayling T (1999) Guidelines for safe disposal of unwanted pharmaceuticals in and after emergencies. World Health Organization. Online
  73. Halling-Sørensen B, Nielsen SN, Lanzky PF, Ingerslev F, Lützhøft H-C, Jørgensen SE (1998) Ocurrence, fate and effects of pharmaceutical substances in the environment. Chemosphere 36 (2): 357–393.CrossRefGoogle Scholar
  74. Halling-Sørensen B, Sengeløv G, Tjørnelund J (2002) Toxicity of tetracyclines and tetracycline degradation products to environmentally relevant bacteria, including selected tetracycline-resistant bacteria. Arch Environ Contam Toxicol 42:263–271.CrossRefGoogle Scholar
  75. Hamscher G, Sczesny S, Höper H, Nau H (2002) Determination of persistent tetracycline residues in soil fertilized with liquid manure by high-performance liquid chromatography with electrospray ionization tandem mass spectrometry. Anal Chem 74:1509–1518.CrossRefGoogle Scholar
  76. Harries JE, Sheahan DA, Jobling S, Matthiessen P, Neal P, Sumpter JP, Tylor T, Zaman N (1997) Estrogenic activity in five United Kingdom rivers detected by measurement of vitellogenesis in caged male trout. Environ Toxicol Chem 16(3): 534–542.CrossRefGoogle Scholar
  77. Heberer T, Verstraeten IM, Meyer MT, Mechlinski A, Reddersen K (2001a) Occurrence and fate of pharmaceuticals during bank filtration - preliminary results from investigations in Germany and the United States. Water Resour Update 120:4–17.Google Scholar
  78. Heberer T, Fuhrmann B, Schmidt-Bäumler K, Tsipi D, Koutsouba V, Hiskia A (2001b) Occurrence of Pharmaceutical Residues in Sewage, River, Ground and Drinking Water in Greece and Berlin (Germany). In: Daughton CG and Jones-Lepp T (eds), American Chemical Society, Symposium series 791, Washington D.C, pp 70–83.Google Scholar
  79. Hilton MJ, Thomas KV (2003) Determination of selected human pharmaceutical compounds in effluent and surface water samples by high-performance liquid chromatography-electrospray tandem mass spectrometry. J Chromat A 1015:129–141.CrossRefGoogle Scholar
  80. Hirsch R, Ternes T, Haberer K, Kratz K-L (1999) Occurrence of antibiotics in the aquatic environment. Sci Tot Environ 225:109–118.CrossRefGoogle Scholar
  81. Hoffman BB (2001) Catecholamines, sympathomimetic drugs and adrenergenic receptor antagonists. In: Hardman JG, Limbird LE (eds) Goodman & Gilman's - The Pharmacological Basis of Therapeutics 10th Ed, McGraw-Hill, New York, USA, pp 215–268.Google Scholar
  82. Hohenblum P, Gans O, Moche W, Scharf S, Lorbeer G (2004) Monitoring of selected estrogenic hormones and industrial chemicals in groundwaters and surface waters in Austria. Sci Tot Environ 333:185–193.CrossRefGoogle Scholar
  83. Holm JV, Rügge K, Bjerg PL, Christensen TH (1995) Occurrence and distribution of pharmaceutical organic compounds in the groundwater downgradient of a landfill (Grinsted, Denmark). Environ SciTechnol 29(5): 1415–1420.CrossRefGoogle Scholar
  84. Huang C-H and Sedlak DL (2001) Analysis of estrogenic hormones in municipal wastewater effluent and surface water using enzyme-linked immunosorbent assay and gas chromatography/ tandem mass spectrometry. Environ Toxicol Chem 20 (1): 133–139.CrossRefGoogle Scholar
  85. Huber MM, Ternes TA, Von Gunten U (2004) Removal of estrogenic activity and formation of oxidation products during ozonation of 17a-ethinylestradiol. Environ Sci Technol 38 (19): 5177–5186.CrossRefGoogle Scholar
  86. Huber MM, Göbel A, Joss A, Hermann N, Löffler D, McArdell CS, Ried A, Siegrist H, Ternes T, Von Gunten U (2005) Oxidation of pharmaceuticals during ozonation of municipal wastewater effluents: a pilot study. Environ Sci Technol 39(11): 4290–4299.CrossRefGoogle Scholar
  87. Ingerslev F and Halling-Sørensen B (2000) Biodegradability properties of sulfonamides in activated sludge. Environ Toxicol Chem 19:2467–2473.CrossRefGoogle Scholar
  88. Ingerslev F and Halling-Sørensen B (2001) Biodegradability of metronidazole, olaquindox, and tylosin and formation of tylosin degradation products in aerobic soil-manure slurries. Ecotoxicol Environ Saf 48(3): 311–320.CrossRefGoogle Scholar
  89. Jacobsen AM, Halling-Sørensen B, Ingerslev F, Hansen SH (2004) Simultaneous extraction of tetracycline, macrolide and sulfonamide antibiotics from agricultural soils using pressurized liquid extraction, followed by solid-phase extraction and liquid chromatography - tandem mass spectrometry. J Chromat A 1038:157–170.CrossRefGoogle Scholar
  90. Jjemba P (2006) Excretion and ecotoxicity of pharmaceutical and personal care products in the environment. Ecotoxicol Environ Saf 63(1): 113–130.CrossRefGoogle Scholar
  91. Jones OAH, Voulvoulis N, Lester JN (2002) Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Res 36:5013–5022.CrossRefGoogle Scholar
  92. Jones OAH, Voulvoulis N, Lester JN (2007) The occurrence and removal of selected pharmaceutical compounds in a sewage treatment works utilizing activated sludge treatment. Environl Pollut 145(3): 738–744.CrossRefGoogle Scholar
  93. Joss A, Andersen H, Ternes T, Richle PR, Siegrist H (2004) Removal of estrogens in municipal wastewater treatment under aerobic and anaerobic conditions: consequences for plant optimization. Environ Sci Technol 38(11): 3047–3055.CrossRefGoogle Scholar
  94. Joss A, Keller E, Alder AC, Göbel A, McArdell CS, Ternes T, Siegrist H (2005) Removal of pharmaceuticals and fragrances in biological wastewater treatment. Water Res 39:3139–3152.CrossRefGoogle Scholar
  95. Jørgensen SE and Halling-Sørensen B (2000) Drugs in the Environment. Chemosphere 40:691–699.CrossRefGoogle Scholar
  96. Kah M, Brown C (2006) Adsorption of ionisable pesticides in soils. Rev Environ Contam Toxicol 188:149–217.CrossRefGoogle Scholar
  97. Karthikeyan KG and Bleam WF (2003) Occurrence of antibiotics in wastewater effluents and their mobility in soils: a case study for Wisconsin. Final Project Report submitted to Wisconsin Department of Natural Resources and Wisconsin Department of Agriculture, Trade, and Consumer Protection. Online
  98. Kay P, Blackwell P, Boxall ABA (2005) Column studies to investigate the fate of veterinary antibiotics in clay soils following slurry application to agricultural land. Chemosphere 60:497–507.CrossRefGoogle Scholar
  99. Kim S, Eichhorn P, Jensen JN, Weber AS, Aga DS (2005) Removal of antibiotics in wastewater: effect of hydraulic and solid retention times on the fate of tetracycline in the activated sludge process. Environ Sci Technol 39(15): 5816–5823.CrossRefGoogle Scholar
  100. Kinney CA, Furlong ET, Zaugg SD, Burkhardt MR, Werner SL, Cahill JD, Jorgensen GR (2006) Survey of organic wastewater contaminants in biosolids destined for land application. Environ Sci Technol 40 (23):7207–7215.CrossRefGoogle Scholar
  101. Kirby MF, Bignell J, Brown E, Craft JA, Davies I, Dyer RA, Feist SW, Joines G, Mathiessen P, Megginson C, Robertson FE, Robinson C (2003) The presence of morphologically intermediate papilla syndrome in United kingdom populations of sand goby (Pomatoschistus spp.): endocrine disruption? Environ Toxicol Chem 22:239–251.Google Scholar
  102. Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB, Buxton HT (2002) Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams 1999–2000: a national reconnaissance. Environ Sci Technol 36:1202–1211.CrossRefGoogle Scholar
  103. Koutsouba V, Heberer T, Fuhrmann B, Schmidt-Baumler K, Tsipi D, Hiskia A (2003) Determination of polar pharmaceuticals in sewage water of Greece by gas chromatography-mass spectrometry. Chemosphere 51:69–75.CrossRefGoogle Scholar
  104. Kühne M, Ihnen D, Möller G, Agthe O (2000) Stability of tetracycline in water and liquid manure. J Vet Med A 47:379–384.CrossRefGoogle Scholar
  105. Kümmerer K, Al-Ahmad A, Mersch-Sundermann V (2000) Biodegradability of some antibiotics, elimination of the genotoxicity and affection of wastewater bacteria in a simple test. Chemosphere 40:701–710.CrossRefGoogle Scholar
  106. Kümmerer K (2001) Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources - a review. Chemosphere 45:957–969.CrossRefGoogle Scholar
  107. Kümmerer K (2004) Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks 2nd Ed. Springer, New York, pp. 3–23.Google Scholar
  108. La Guardia MJ, Hale RC, Harvey EP, Bush EO, Mainor TM, Gaylor MO (2004) Organic contaminants of emerging concern in land-applied sewage sludge (biosolids). J Residuals Sci Technol 1:111–122.Google Scholar
  109. Lalumera GM, Calamari D, Galli P, Castiglioni S, Crosa G, Fanelli R (2004) Preliminary investigation on the environmental occurrence and effects of antibiotics used in aquaculture in Italy. Chemosphere 54:661–668.CrossRefGoogle Scholar
  110. Lam MW, Young C, Brain RA, Johnson DJ, Hanson MA, Wilson CJ, Richards SM, Solomon KR, Mabury SA (2004) Aquatic persistence of eight pharmaceuticals in a microcosm study. Environ Toxicol Chem 23:1431–1440.CrossRefGoogle Scholar
  111. Langenkamp H, Part P (2001) Organic contaminants in sewage sludge for agricultural use. Erhardt W, Prüeß A (eds) European Commission. Online
  112. Larsen TA, Lienert J, Joss A, Siegrist H (2004) How to avoid pharmaceuticals in the aquatic environment. J Biotechnol 113:295–304.CrossRefGoogle Scholar
  113. Larsson J, Pedro C, Paxeus N (2007) Effluent from drug manufactures contains extremely high levels of pharmaceuticals. J Hazard Mater 148:751–755.CrossRefGoogle Scholar
  114. Latch DE, Stender BL, Packer JL, Arnold WA, McNeill K (2003) Photochemical fate of pharmaceuticals in the environment: cimetidine and ranitidine. Environ Sci Technol 37:3342–3350.CrossRefGoogle Scholar
  115. Lindberg RH, Wennberg P, Johansson MI, Tysklind M, Andersson BAV (2005) Screening of human antibiotic substances and determination of weekly mass flows in five sewage treatment plants in Sweden. Environ Sci Technol 39:3421–3429.CrossRefGoogle Scholar
  116. Lindberg RH, Olofsson U, Rendahl P, Johansson MI, Tysklind M, Andersson BAV (2006) Behavior of fluoroquinolones and trimethoprim during mechanical, chemical, and active sludge treatment of sewage water and digestion of sludge. Environ Sci Technol 40:1042–1048.CrossRefGoogle Scholar
  117. Lindqvist N, Tuhkanen T, Kronberg L (2005) Occurrence of acidic pharmaceuticals in raw and treated sewage and in receiving waters. Water Res 39:2219–2228.CrossRefGoogle Scholar
  118. López de Alda MJ, Gil A, Paz E, Barceló D (2002) Occurrence and analysis of estrogens and progestogens in river sediments by liquid chromatography- electrospray-mass spectrometry. Analyst 127:1299–1304.Google Scholar
  119. Löffler D, Römbke J, Meller M, Ternes T (2005) Environmental fate of pharmaceuticals in water/sediment systems. Environ Sci Technol 39:5209–5218.CrossRefGoogle Scholar
  120. Macrolide antibiotics (2000) In: An A-Z of Medicinal Drugs. Oxford University Press 2000. Oxford Reference online. Oxford University Press. York University (accessed 18 January 2007), online-
  121. Mahley RW, Bersot TP (2001) Drug therapy for hypercholesterolemia and dyslipidemia. In: Hardman JG, Limbird LE (eds) Goodman & Gilman's - The Pharmacological Basis of Therapeutics 10th Ed, McGraw-Hill, New York, USA, pp 971–1002.Google Scholar
  122. Martinovic D, Hogarth WT, Jones RE, Sorensen PW (2007) Environmental estrogens suppress hormones, behavior, and reproductive fitness in male fathead minnows. Environ Toxicol Chem 26:271–278.CrossRefGoogle Scholar
  123. McGechan MB and Lewis DR (2002) Soil and water: transport of particulate and colloid-sorbed contaminants through soil, part 1: general principles. Biosyst Eng 83:255–273.CrossRefGoogle Scholar
  124. McNamara JO (2001) Drugs effective in the therapy of the epilepsies. In: Hardman JG, Limbird LE (eds) Goodman & Gilman's - The Pharmacological Basis of Therapeutics 10th Ed, McGraw-Hill, New York, USA, pp 521–548.Google Scholar
  125. Metcalfe C, Miao X-S, Koenig BG, Struger J (2003) Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower Great Lakes, Canada. Environ Toxicol Chem 22:2881–2889.CrossRefGoogle Scholar
  126. Miao X-S, Bishay F, Chen M, Metcalfe C (2004) Occurrence of antimicrobials in the final effluents of wastewater treatment plants in Canada. Environ Sci Technol 38:3533–3541.CrossRefGoogle Scholar
  127. Miao X-S, Yang J-J, Metcalfe C (2005) Carbamazepine and its metabolites in wastewater and in biosolids in a municipal wastewater treatment plant. Environ Sci Technol 39:7469–7475.CrossRefGoogle Scholar
  128. Nowara A, Burhenne J, Spiteller M (1997) Binding of fluoroquinolone carboxylic acid derivatives to clay minerals. J Agric Food Chem 45:1459–1463.CrossRefGoogle Scholar
  129. Oaks JL, Gilbert M, Virani MZ, Watson RT, Meteyer CU, Rideout BA, Shivaprasad HL, Ahmed S, Chaudhry MJ, Arshad M, Mahmood S, Ali A, Khan AA (2004) Diclofenac residues as the cause of vulture population decline in Pakistan. Nature 427:630–633.CrossRefGoogle Scholar
  130. Oppel J, Broll G, Löffler D, Römbke J, Meller M, Ternes T (2004) Leaching behaviour of pharmaceuticals in soil-testing-systems: a part of an environmental risk assessment for groundwater protection. Sci Tot Environ 328:265–273.CrossRefGoogle Scholar
  131. Öllers S, Singer HP, Fässler P, Müller SR (2001) Simultaneous quantification of neutral and acidic pharmaceuticals and pesticides at the low - ng/L level in surface and waste water. J Chromat A 911:225–234.CrossRefGoogle Scholar
  132. Packer JL, Werner J.J, Latch DE, McNeill K, Arnold W (2003) Photochemical fate of pharmaceuticals in the environment: naproxen, diclofenac, clofibric acid, and ibuprofen. Aquat Sci 65:342–351.CrossRefGoogle Scholar
  133. Parrot JL, Blunt B (2005) Life-cycle exposure of fathead minnows (Pimephales promelas) to an ethinylestradiol concentration below 1 ng/L reduces egg fertilization success and demasculinizes males. Environ Toxicol 20:131–141.CrossRefGoogle Scholar
  134. Pascoe D, Karntanut W, Muller CT (2003) Do pharmaceuticals affect freshwater invertebrates? A study with the cnidarian Hydra vulgaris. Chemosphere 51:521–528.CrossRefGoogle Scholar
  135. Pedersen JA, Soliman M, Suffet IHM (2005) Human pharmaceuticals, hormones and personal care product ingredients in runoff from agricultural fields irrigated with treated wastewater. J Agric Food Chem 53:1625–1632.CrossRefGoogle Scholar
  136. Petri WA (2001a) Antimicrobial agents: penicillins, cephalosporins, and other β-lactam antibiotics. In: Hardman JG, Limbird LE (eds) Goodman & Gilman's - The Pharmacological Basis of Therapeutics 10th Ed, McGraw-Hill, New York, USA, pp 1189–1218.Google Scholar
  137. Petri WA (2001b) Antimicrobial agents: sulfonamides, trimethoprim- sulfamethoxazole, quinolones, and agents for urinary tract infections. In: Hardman JG, Limbird LE (eds) Goodman & Gilman's - The Pharmacological Basis of Therapeutics 10th Ed, McGraw-Hill, New York, USA, pp 1171–1188.Google Scholar
  138. Petrovic M, Gonzalez S, Barceló D (2003) Analysis and removal of emerging contaminants in wastewater and drinking water. Trends Anal Chem 22:685–696.CrossRefGoogle Scholar
  139. Pignatello JJ (1998) Soil organic matter as a nanoporous sorbent of organic pollutants. Adv Colloid Interface Sci 76–77:445–467.CrossRefGoogle Scholar
  140. POSEIDON project (EVK1-CT-2000-00047) 2005. Assessment of technologies for the removal of pharmaceuticals and personal care products in sewage and drinking water facilities to improve the indirect potable water reuse. Final Report,
  141. Pouliquen H, Le Bris H (1996) Sorption of oxolinic acid and oxytetracycline to marine sediments. Chemosphere 33:801–815.CrossRefGoogle Scholar
  142. Quinn B, Gagné F, Blaise C (2008) An investigation into the acute and chronic toxicity of eleven pharmaceuticals (and their solvents) found in wastewater effluent on the cnidarian, Hydra attenuate. Sci Total Environ 389:306–314.CrossRefGoogle Scholar
  143. Quinolones (2000) In: An A-Z of Medicinal Drugs. Oxford University Press 2000. Oxford Reference online. Oxford University Press. York University (accessed 18 January 2007), online
  144. Rabølle M and Spliid NH (2000) Sorption and mobility of metronidazole, olaquindox, oxytetracycline and tylosin in soil. Chemosphere 40:715–722.CrossRefGoogle Scholar
  145. Reddersen K, Heberer T, Dünnbier U (2002) Identification and significance of phenazone drugs and their metabolism in ground- and drinking water. Chemosphere 49:539–544.CrossRefGoogle Scholar
  146. Renew JE, Huang C-H (2004) Simultaneous determination of fluoroquinolone, sulfonamide, and trimethoprim antibiotics in wastewater using tandem solid phase extraction and liquid chromatography-electrospray mass spectrometry. J Chromat A 1042:113–121.CrossRefGoogle Scholar
  147. Richardson ML, Bowron JM (1985) The fate of pharmaceutical chemicals in the aquatic environment. J Pharm Pharmacol 37:1–12.Google Scholar
  148. Roberts LJ, Morrow JD (2001) Analgesic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout. In: Hardman JG, Limbird LE (eds) Goodman & Gilman's - The Pharmacological Basis of Therapeutics 10th Ed, McGraw-Hill, New York, USA, pp 687–732.Google Scholar
  149. Rogers HR (1996) Sources, behaviour and fate of organic contaminants during sewage treatment and in sewage sludges. Sci Total Environ 185:3–26.CrossRefGoogle Scholar
  150. Sacher F, Lange FT, Brauch H-J, Blankenhorn I (2001) Pharmaceuticals in groundwaters. Analytical methods and results of a monitoring program in Baden-Württemberg, Germany. J Chromat A 938:199–210.CrossRefGoogle Scholar
  151. Sanders-Bush E. and Mayer SE (2001) 5-Hydroxytryptamine (serotonin): receptor agonists and antagonists. In: Hardman JG, Limbird LE (eds) Goodman & Gilman's - The Pharmacological Basis of Therapeutics 10th Ed, McGraw-Hill, New York, USA, pp 269–290.Google Scholar
  152. Scheytt T, Grams S, Rejman-Rasinski E, Heberer T, Stan H-J (2001) Pharmaceuticals in groundwater: clofibric acid beneath sewage farms south of Berlin, Germany. In: Daughton CG and Jones-Lepp T (eds), American Chemical Society, Symposium series 791, Washington D.C, pp 84–99.Google Scholar
  153. Scheytt T, Mersmann P, Lindstädt R, Heberer T (2005) Determination of sorption coefficients of pharmaceutically active substances carbamazepine, diclofenac, and ibuprofen, in sandy sediments. Chemosphere 60:245–253.CrossRefGoogle Scholar
  154. Schlüsener MP and Bester K (2006) Persistence of antibiotics such as macrolides, tiamulin and salinomycin in soil. Environ Pollut 143:565–571.CrossRefGoogle Scholar
  155. Schwab BW, Hayes EP, Fiori JM, Mastrocco FJ, Roden NM, Cragin D, Meyerhoff RD, D'Aco VJ, Anderson PD (2005) Human pharmaceuticals in US surface waters: A human health risk assessment. Regul Toxicol Pharmacol 42(3):296–312.CrossRefGoogle Scholar
  156. Sedlak DL and Pinkston KE (2001) Factors affecting the concentrations of pharmaceuticals released to the aquatic environment. Water Resour Update 120:56–64.Google Scholar
  157. Selective serotonin reuptake inhibitor (2006) In: A dictionary of Psychology. Colman, A.M. (ed.) Oxford University Press 2006. Oxford Reference online. Oxford University Press. York University (accessed 18 January 2007)
  158. Servos MR, Bennie DT, Burnison BK, Jurkovic A, McInnis R, Neheli T, Schnell A, Seto P, Smyth SA, Ternes T (2005) Distribution of estrogens 17 beta-estradiol and estrone, in Canadian municipal wastewater treatment plants. Sci Total Environ 336(1–3):155–170.Google Scholar
  159. Skadsen JM, Rice BL, Meyering DJ (2004) The occurrence and fate of pharmaceuticals, personal care products and endocrine disrupting compounds in a municipal water use cycle: a case study in the city of Ann Arbor. Water Utilities and Fleis & VandenBrink Engineering, Inc., City of Ann Arbor.Google Scholar
  160. Snyder S, Wert E, Rexing DJ, Zegers RE, Drury DD (2006) Ozone oxidation of endocrine disruptors and pharmaceuticals in surface water and wastewater. Ozone Sci Eng 28:445–460.CrossRefGoogle Scholar
  161. Stackelberg PE, Furlong ET, Meyer MT, Zaugg SD, Henderson AK, Reissman DB (2004) Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant. Sci Total Environ 329:99–113.CrossRefGoogle Scholar
  162. Stackelberg PE, Gibs J, Furlong ET, Meyer M, Zaugg SD, Lippincott RL (2007) Efficiency of conventional drinking-water-treatment processes in removal of pharmaceuticals and other organic compounds. Sci Total Environ 377:255–272.CrossRefGoogle Scholar
  163. Stanley JK, Ramirez AJ, Chambliss CK, Brooks BW (2007) Enantiospecific sublethal effects of the antidepressant fluoxetine to a model aquatic vertebrate and invertebrate. Chemosphere 69:9–16.CrossRefGoogle Scholar
  164. Steger-Hartmann T, Kümmerer K, Schecker J (1996) Trace analysis of the antineoplastics ifosfamide and cyclophosphamide in sewage water by two-step solid-phase extraction and gas chromatography - mass spectrometry. J Chromat A 726:179–184.CrossRefGoogle Scholar
  165. Stumpf M, Ternes T, Wilken R-D, Rodrigues SV, Baumann W (1999) Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil. Sci Total Environ 225:135–141.CrossRefGoogle Scholar
  166. Syracuse Research Corporation, Phys Prop Database (2004) – online
  167. Tauxe-Wuersch A, De Alencastro LF, Grandjean D, Tarradellas J (2005) Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment. Water Res 39:1761–1772.CrossRefGoogle Scholar
  168. Ter laak TL (2005) Sorption to soil of hydrophobic and ionic organic compounds: measurement and modelling. Ph.D. Dissertation (online), Utrecht University, The Netherlands, September 2005Google Scholar
  169. Ter Laak TL, Gebbink W, Tolls J (2006) The effect of pH and ionic strength on the sorption of sulfachloropyridizine, tylosin, and oxytetracycline to soil. Environ Toxicol Chem 25:904–911.CrossRefGoogle Scholar
  170. Ternes T (1998) Occurrence of drugs in German sewage treatment plants and rivers. Water Res 32:3245–3260.CrossRefGoogle Scholar
  171. Ternes T, Stumpf M, Mueller J, Haberer K, Wilken R-D, Servos M. (1999) Behaviour and occurrence of estrogens in municipal sewage treatment plants - I. investigations in Germany, Canada and Brazil. Sci Total Environ 225:81–90.Google Scholar
  172. Ternes T, Hirsch R (2000) Occurrence and behavior of X-ray contrast media in sewage facilities and the aquatic environment. Environ Sci Technol 34:2741–2748.CrossRefGoogle Scholar
  173. Ternes T (2001a) Pharmaceuticals and Metabolites as Contaminants of the Aquatic Environment. In: Daughton CG and Jones-Lepp T (eds), American Chemical Society, Symposium series 791, Washington D.C, pp 39–54.Google Scholar
  174. Ternes T, Bonerz M, Schmidt T (2001b) Determination of neutral pharmaceuticals in wastewater and rivers by liquid chromatography - electrospray tandem mass spectrometry. J Chromat A 938:175–185CrossRefGoogle Scholar
  175. Ternes TA, Andersen H, Gilberg D, Bonerz M (2002a) Determination of estrogens in sludge and sediments by liquid extraction and GC/MS/MS. Anal Chem 74:3498–3504.CrossRefGoogle Scholar
  176. Ternes T, Meisenheimer M, McDowell D, Sacher F, Brauch H-J, Haist-Gulde B, Preuss G, Wilme U, Zulei-Seibert N (2002b) Removal of pharmaceuticals during drinking water treatment. Environ Sci Technol 36:3855–3863.CrossRefGoogle Scholar
  177. Ternes T, Stüber J, Herrmann N, McDowell D, Ried A, Kampmann M, Teiser B (2003) Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater? Water Res 37:1976–1982.CrossRefGoogle Scholar
  178. Ternes T, Joss A, Siegrist H (2004a) Scrutinizing pharmaceuticals and personal care products in wastewater treatment. Environ Sci Technol 38:393A–398A.CrossRefGoogle Scholar
  179. Ternes T, Hermann N, Bonerz M, Knacker T, Siegrist H, Joss A (2004b) A rapid method to measure the solid-water distribution coefficient (Kd) for pharmaceuticals and musk fragrances in sewage sludge. Water Res 38:4075–4084.CrossRefGoogle Scholar
  180. Ternes T, Bonerz M, Herrmann N, Teiser B, Andersen HR (2007) Irrigation of treated wastewater in Braunschweig, Germany: an option to remove pharmaceuticals and musk fragrances. Chemosphere 66:894–904.CrossRefGoogle Scholar
  181. Tetracyclines (2000) In: An A-Z of Medicinal Drugs. Oxford University Press 2000. Oxford Reference online. Oxford University Press. York University (accessed 18 January 2007), online
  182. Thiele-Bruhn S (2003) Pharmaceutical antibiotic compounds in soils - a review. J Plant Nut Soil Sci 166:145–167.CrossRefGoogle Scholar
  183. Thomas KV and Hilton MJ (2004) The occurrence of selected human pharmaceutical compounds in UK estuaries. Mar Pollut Bull 49:436–444.CrossRefGoogle Scholar
  184. Tixier C, Singer HP, Oellers S, Müller SR (2003) Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen. Environ Sci Technol 37:1061–1068.CrossRefGoogle Scholar
  185. Tolls J (2001) Sorption of veterinary pharmaceuticals in soils: a review. Environ Sci Technol 35:3397–3406.CrossRefGoogle Scholar
  186. Topp E, Hendel JG, Lu Z, Chapman R (2006) Biodegradation of caffeine in agricultural soils. Can J Soil Sci 86(2–3): 533–544.Google Scholar
  187. Topp E, Monteiro SC, Beck A, Coelho BB, Boxall ABA, Duenk PW, Kleywegt S, Lapen DR, Payne M, Sabourin L, Li H, Metcalfe CD (2008a) Runoff of pharmaceuticals and personal care products following application of biosolids to an agricultural field. Sci Total Environ 396:52–59.CrossRefGoogle Scholar
  188. Topp E, Hendel J, Lapen D, Chapman R (2008b) Fate of the non-steroidal anti-inflammatory drug naproxen in agricultural soil receiving liquid municipal biosolids. Environ Toxicol Chem (in press).Google Scholar
  189. Urase T, Kawaga C, Kikuta T (2005) Factors affecting removal of pharmaceutical substances and estrogens in membrane separation bioreactors. Desalination 178:107–113.CrossRefGoogle Scholar
  190. Velagaleti R, Burns PK, Gill M, Prothro J (2002) Impact of current good manufacturing practices and emission regulations and guidances on the discharge of pharmaceutical chemicals into the environment from manufacturing, use, and disposal. Environ Health Perspect 110:213–220.CrossRefGoogle Scholar
  191. Vieno NM, Tuhkanen T, Kronberg L (2006) Analysis of neutral and basic pharmaceuticals in sewage treatment plants and in recipient rivers using solid phase extraction and liquid chromatography - tandem mass spectrometry detection. J Chromat A 1134(1–2):101–111.CrossRefGoogle Scholar
  192. Webb S, Ternes T, Gibert M, Olejniczak K (2003) Indirect human exposure to pharmaceuticals via drinking water. Toxicol Lett 142:157–167.CrossRefGoogle Scholar
  193. Weigel S, Kuhlmann J, Hühnerfuss H (2002) Drugs and personal care products as ubiquitous pollutants: occurrence and distribution of clofibric acid, caffeine and DEET in the North Sea. Sci Total Environ 295:131–141.CrossRefGoogle Scholar
  194. Weigel S, Berger U, Jensen E, Kallenborn R, Thoresen H, Hühnerfuss H (2004) Determination of selected pharmaceuticals and caffeine in sewage and seawater from Tromsø/Norway with emphasis on ibuprofen and its metabolites. Chemosphere 56:583–592.CrossRefGoogle Scholar
  195. Westerhoff P, Yoon Y, Snyder S, Wert E (2005) Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment. Environ Sci Technol 39:6649–6663.CrossRefGoogle Scholar
  196. Wiegel S, Aulinger A, Brockmeyer R, Harms H, Löffler J, Reincke H, Schmidt R, Stachel B, von Tümpling W, Wanke A (2004) Pharmaceuticals in the river Elbe and its tributaries. Chemosphere 57:107–126.Google Scholar
  197. Wilkinson GR (2001) Pharmacokinetics: the dynamic of drug absorption, distribution and elimination. In: Hardman JG, Limbird LE (eds) Goodman & Gilman's - The Pharmacological Basis of Therapeutics 10th Ed, McGraw-Hill, New York, USA, pp 3–30.Google Scholar
  198. Williams RT (2005) Human health pharmaceuticals in the environment: an introduction. In: Williams RT (ed) Human pharmaceuticals: assessing the impacts on aquatic ecosystems, Allen Press/ACG Publishing, pp 1–45.Google Scholar
  199. Xia K, Bhandari A, Das K, Pillar G (2005) Occurrence and fate of pharmaceuticals and personal care products (PPCPs) in biosolids. J Environ Qual 34:91–104.CrossRefGoogle Scholar
  200. Yang S, Carlson KH (2004a) Routine monitoring of antibiotics in water and wastewater with a radioimmunoassay technique. Water Res 38:3155–3166.CrossRefGoogle Scholar
  201. Yang S and Carlson KH (2004b) Solid-phase extraction-high performance liquid chromatography- ion trap mass spectrometry for analysis of trace concentrations of macrolide antibiotics in natural and waste water matrices. J Chromat A 1038:141–155.CrossRefGoogle Scholar
  202. Yu JT, Bouwer EJ, Coelhan M (2006) Occurrence and biodegradability studies of selected pharmaceuticals and personal care products in sewage effluent. Agric Water Manag 86 (1–2): 72–80.CrossRefGoogle Scholar
  203. Zepp RG, Baughman GL, Schlotzhauer PF (1981) Comparison of photochemical behavior of various humic substances in water: I. Sunlight induced reactions of aquatic pollutants photosensitized by humic substances. Chemosphere 10:109–117.CrossRefGoogle Scholar
  204. Zuccato E, Castiglioni S, Fanelli R (2005a) Identification of the pharmaceuticals for human use contaminating the Italian aquatic environment. J Hazard Mater 122:205–209.CrossRefGoogle Scholar
  205. Zuccato E, Chiabrando C, Castiglioni S, Calamari D, Bagnati R, Schiarea S, Fanelli R (2005b) Cocaine in surface waters: a new evidence-based tool to monitor community drug abuse. Environ Health: A Global Access Science Source 4:14CrossRefGoogle Scholar
  206. Zwiener C, Frimmel FH (2000) Oxidative treatment of pharmaceuticals in water. Water Res 34:1881–1885.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.University of YorkYorkUK
  2. 2.Central Science LaboratoryYorkUK

Personalised recommendations